Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cordis coronary stent patent infringement trial begins Feb. 9 in Delaware federal court.

This article was originally published in The Gray Sheet

Executive Summary

CORDIS SEEKING TO BLOCK SALES OF GUIDANT ACS Rx MULTI-LINK IN U.S., claiming the flexible design of the recently launched coronary stent infringes a key patent owned by Cordis parent Johnson & Johnson related to the Palmaz-Schatz and Crown coronary stent systems.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel